全球MASH相关肝癌趋势:基于2021年全球疾病负担的系统分析
该研究分析2000至2021年全球疾病负担数据,评估MASH相关原发性肝癌的年龄标化发病率、死亡率和伤残调整生命年(DALYs)。全球MASH相关PLC发病(+98%)、死亡(+93%)和DALYs(+76%)均大幅上升,仅MASH相关PLC死亡率上升(APC +0.46,95%CI 0.33%-0.59%)。非洲和低社会人口指数国家年龄标化发病率、死亡和DALYs最高。
要点
- 2000至2021年全球MASH相关PLC发病增加98%、死亡增加93%、DALYs增加76%。
- 仅MASH相关PLC死亡率上升,APC为+0.46(95%CI 0.33%-0.59%)。
- 非洲和低社会人口指数国家MASH相关PLC年龄标化发病、死亡和DALYs最高。
核心结论
- 过去20年MASH相关PLC负担上升,但存在社会人口学和地理差异。
- 全球需采取紧急策略以减轻MASH相关PLC及其代谢驱动因素的流行。
研究设计与样本
- 分析2000至2021年全球疾病负担研究数据,按地理区域、社会人口指数、年龄和性别分层。
- 评估MASH相关原发性肝癌的年龄标化发病率、死亡率和DALYs。
主要发现
- 全球MASH相关PLC发病例数42,290例、死亡40,920例、DALYs 995,470。
- 全球MASH相关PLC发病增加98%、死亡增加93%、DALYs增加76%。
- 仅MASH相关PLC死亡率上升,APC为+0.46(95%CI 0.33%-0.59%)。
- 非洲和低社会人口指数国家MASH相关PLC年龄标化发病率、死亡和DALYs最高。
- 女性DALYs上升(APC 0.24%,95%CI 0.06%-0.42%),男性保持稳定。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are the leading causes of liver disease and are emerging as the main risk factors for primary liver cancer (PLC). However, updated global data on MASH remain scarce. METHODS: This study analyzed data from the Global Burden of Disease study between 2000 and 2021 to assess the age-standardized incidence, mortality, and disability-adjusted life years (DALYs) from MASH-associated PLC, stratified by geographical region, sociodemographic index, age, and sex. RESULTS: There were 42,290 incident cases, 40,920 deaths, and 995,470 DALYs from PLC globally. Global incidence (+98%), death (+93%), and DALYs (+76%) from MASH-associated PLC increased steeply over the study period. Among different etiologies, only MASH-associated PLC had increased mortality rates (annual percent change [APC], +0.46; 95% confidence interval [CI], 0.33%-0.59%). Africa and low sociodemographic index countries exhibited the highest age-standardized incidence, death, and DALYs from MASH-associated PLC. DALYs increased in females (APC, 0.24%; 95% CI, 0.06%-0.42%), whereas they remained stable in males. Americas experienced the highest percentage increase in age-standardized incidence rate (APC, 2.09%; 95% CI, 2.02%-2.16%), age-standardized death rate (APC, 1.96%; 95% CI, 1.69%-2.23%), and age-standardized DALYs (APC, 1.96%; 95% CI, 1.63%-2.30%) from MASH-associated PLC. CONCLUSIONS: Over the past 2 decades, the burden of MASH-associated PLC has risen, though there are sociodemographic and geographic disparities. This necessitates urgent strategies across the globe to mitigate the epidemic of MASH-associated PLC as well as its metabolic drivers.
引用
- Danpanichkul P, Suparan K, Kaeosri C, et al. Global Trend of MASH-associated Liver Cancer: A Systematic Analysis From the Global Burden of Disease 2021. Clin Gastroenterol Hepatol. 2024. PMID: 39694213. doi:10.1016/j.cgh.2024.10.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。